Susan Blum - 23 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Chief Financial Officer
Signature
/s/ Beth Zelnick Kaufman, attorney-in-fact
Issuer symbol
CRMD
Transactions as of
23 Jan 2026
Net transactions value
-$71,006
Form type
4
Filing time
27 Jan 2026, 21:31:09 UTC
Previous filing
03 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Blum Susan Chief Financial Officer C/O CORMEDIX INC.,, 389 INTERPACE PKWY, SUITE 450, PARSIPPANY /s/ Beth Zelnick Kaufman, attorney-in-fact 27 Jan 2026 0001792253

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Award $0 +72,820 +104% $0.000000 142,506 23 Jan 2026 Direct F1
transaction CRMD Common Stock Tax liability $71,006 -9,767 -6.9% $7.27 132,739 23 Jan 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

Remarks:

Exhibit 24.1 - Power of Attorney